ISRG
WAITIntuitive Surgical, Inc.
$353.33
+0.10%delayed
News – · Trend – · inside triggers –
Expected move (1d)
▼ $338.59to$368.07 ▲
ATR ±$14.74 (+4.17%)Implied ±$11.45 (+3.24%)
Entry Reference
Price / prev close$353.33 / $352.97
Day range$348.88 – $355.09
52-wk range$328.57 – $603.88(9%)
Volume vs avg0.80×
ATR (14d)$14.74
MA 8 / 21$348.53 / $377.83
MA 50 / 200$399.39 / $481.88
Call ▲ / Put ▼ trigger$356.45 / $349.49
+1 / +2 ATR$368.07 / $382.81
-1 / -2 ATR$338.59 / $323.85
Support: 328.57
Resistance: 396.68 417.74 430.85
Near-the-money contracts
exp 2026-08-07Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 347.5 | $10.70 | 63% | 0.60 | -0.97 | 4 |
| 350 | $8.20 | 43% | 0.59 | -0.68 | 59 |
| 352.5 | $7.00 | 43% | 0.53 | -0.69 | 121 |
| 355 | $5.70 | 41% | 0.48 | -0.66 | 94 |
| 357.5 | $5.15 | 40% | 0.42 | -0.63 | 20 |
| 360 | $4.50 | 43% | 0.38 | -0.65 | 97 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 345 | $3.15 | 40% | -0.30 | -0.54 | 51 |
| 347.5 | $4.10 | 40% | -0.36 | -0.57 | 15 |
| 350 | $5.00 | 39% | -0.41 | -0.57 | 194 |
| 352.5 | $4.45 | 40% | -0.47 | -0.60 | 18 |
| 355 | $5.80 | 39% | -0.52 | -0.59 | 32 |
| 360 | $8.65 | 41% | -0.63 | -0.58 | 36 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Intuitive Surgical (ISRG) vs. Medtronic (MDT): Which MedTech Stock Looks Better Positioned for Growth?1d ago
- TEM Q2 Loss Narrower Than Expected, Revenues Beat, Stock Up1d ago
- Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know1d ago
- UBS reveals what’s next for Intuitive Surgical stock2d ago
- Is ISRG Winning the Next Phase of Robotic Surgery Beyond Urology?2d ago
- ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise2d ago
- HSBC Downgrades Intuitive Surgical to Hold, Announces $931 Price Target2d ago
- Intuitive Surgical (ISRG) Could Be 43% Undervalued On Bylaw Changes And Share Price Weakness3d ago
- This Stock Is Knocking on the Door of the Dividend Kings -- and Wall Street Thinks It Has Room to Run3d ago
- The Best House On The Block Costs The Most: ISRG3d ago
- Boston Scientific Q2 Earnings & Revenues Top Estimates, Stock Climbs3d ago
- ISRG Q2 Earnings Call Signals Durable Demand & U.S. Caution4d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.